Efficacy and safety of low-dose oral lenalidomide in refractory cutaneous lupus erythematosus: an open series of 19 cases.
V ReymannD BessisB BergeretDan LipskerA Du-ThanhN TerrailM DandurandOlivier DereurePublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)